Overview
New Conversations About Long-Acting Reversible Contraceptives: Patient Stories and Expert Reflections
Click the"View Activity" button to view this activity.
View ActivityCME/CE is no longer available for this activity
These powerful and captivating real-world patient stories capture how women are approaching decisions regarding contraception during an era in which access to reproductive health care services is changing. These stories highlight the challenges and barriers faced by women along with the myriad of factors that fuel unmet needs relative to contraception in the U.S. today. An expert provides insightful perspectives on these stories and reviews the latest data and guidance on the appropriate use of long-acting reversible contraceptives (LARCs) to reduce unintended pregnancy rates. Don’t miss this powerful documentary-style education that helps you improve access to LARCs and better ensure that your patients receive the best possible care.
This activity is intended for OB/GYNs, internists, primary care physicians, and advanced practice providers (NPs & PAs) in both specialty and primary practice.
Despite having the highest rates of effectiveness amongst contraceptives, few women in the U.S. use LARCs, placing them at risk of unintended pregnancies. Myriad of clinician, systemic, and patient factors contribute to low rates of use. Education on the appropriate use of LARCs along with proper insertion techniques has been demonstrated to increase their use and reduce unintended pregnancy rates. Expanding the number of providers with background in LARC use can improve access and use.
Upon completion of this activity, learners will be able to:
• Outline barriers that impede access to LARCs
• Review current clinical guidelines regarding the use of IUDs and implants for contraception
• Identify appropriate patients for long-acting reversible contraceptives
• Employ strategies to counsel patients on various forms of contraceptives
• Outline barriers that impede access to LARCs
• Review current clinical guidelines regarding the use of IUDs and implants for contraception
• Identify appropriate patients for long-acting reversible contraceptives
• Employ strategies to counsel patients on various forms of contraceptives
Sponsored by the Academy for Continued Healthcare Learning (ACHL).
Supported by an educational grant from Organon.
Sarah Horvath, MD, MSHP (Chair)
Assistant Professor of Obstetrics and Gynecology
Penn State Health Obstetrics and Gynecology
Hershey, PA
Assistant Professor of Obstetrics and Gynecology
Penn State Health Obstetrics and Gynecology
Hershey, PA
C. Nicole Swiner, MD (Faculty)
Family Medicine/General Medicine Physician
Durham, NC
The Academy for Continued Healthcare Learning (ACHL) requires that the faculty participating in an accredited continuing education activity disclose all affiliations or other financial relationships within 24 months (1) with the manufacturers of any commercial product(s) and/or provider(s) of commercial services discussed in an educational presentation and (2) with any ineligible companies. All relevant financial relationships have been mitigated prior to this activity.
The following financial relationships have been provided:
Sarah Horvath, MD, MSHP, (Chair)
Honorarium Recipient (Trainer): Organon
C. Nicole Swiner, MD, (Faculty)
No financial relationships to disclose
Discussion of Off-Label, Investigational, or Experimental Drug/Device Use: None
ACHL staff members, patient interviewees, and others involved with the planning, development, and review of the content for this activity have no relevant affiliations or financial relationships to disclose.
The content for this activity was developed independently of any ineligible company. All materials are included with permission. The opinions expressed are those of the faculty and are not to be construed as those of the publisher or grantor(s).
This educational activity was planned and produced in accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education. Recommendations involving clinical medicine in a continuing medical education (CME/CE) activity must be based on evidence that is accepted within the profession of medicine as adequate justification for their indications and contraindications in the care of patients. All scientific research referred to, reported, or used in CME/CE in support or justification of a patient care recommendation must conform to the generally accepted standards of experimental design, data collection, and analysis.
This CME/CE activity might describe the off-label, investigational, or experimental use of medications and/or devices that may exceed their FDA-approved labeling. Physicians should consult the current manufacturers’ prescribing information for these products. ACHL requires the speaker to disclose that a product is not labeled for the use under discussion.
This activity will take approximately 60 minutes to complete. To receive credit, learners are required to complete the pretest, view the online activity, and complete the posttest and evaluation. To receive credit, 66% must be achieved on the posttest. A certificate will be immediately available. There is no fee to participate in the activity or for the generation of the certificate.
The Academy for Continued Healthcare Learning is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The Academy for Continued Healthcare Learning designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physician assistants, nurse practitioners, and nurses may participate in this educational activity and earn a certificate of completion as AAPA, AANP, and ANCC accept AMA PRA Category 1 Credits™ through their reciprocity agreements.
